KRAS and pancreatic neoplasm: We first compared the uptake of these statin-dye conjugates in two distinct pancreatic cancer cell types: Panc1, featuring a KRAS G12D mutation (KRASG12D), and BxPC3 with KRASWT using confocal microscopy.